Skip to main content.

aducanumab

Picture of Darlene Donloe
Aducanumab is the first new drug approved to treat Alzheimer’s disease in nearly 20 years. But some in the medical community were stunned by the approval.
Picture of Trudy  Lieberman
The media, the medical community, and academic drug experts all quickly questioned the FDA’s approval process — a rare occurrence.

Announcements

Join us for a conversation on the latest COVID thread with Dr. Céline Gounder, a leading infectious disease expert, epidemiologist, medical analyst and host of the COVID podcast “Epidemic.” We'll discuss the emerging research, clarify what we know and don’t, and help attendees think through where the pandemic takes us from here. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth